Basic Search
|
Summaries
|
Advanced SearchViolation Tracker Individual Record
Company: Sandoz Inc.
Current Parent Company:
Sandoz Group
Parent at the Time of the Penalty Announcement:
subscribe to see this data field
Recap of Ownership Changes:
subscribe to see this data field
Penalty: $185,000,000
Year: 2021
Date: October 1, 2021
Offense Group: government-contracting-related offenses
Primary Offense: False Claims Act and related
Secondary Offense: price-fixing or anti-competitive practices
Mega-Scandal:
Drug Pricing Abuses
Violation Description: Three generic pharmaceutical manufacturers, Taro Pharmaceuticals USA, Inc., Sandoz Inc. and Apotex Corporation, agreed to pay a total of $447.2 million to resolve alleged violations of the False Claims Act arising from conspiracies to fix the price of various generic drugs.
Level of Government: federal
Action Type: agency action
Agency: Justice Department Civil Division
Civil or Criminal Case: civil
HQ Country of Current Parent: Switzerland
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data:
(click here)
Archived Source:
(click here)
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the
Update Log.
